Company intelligence
INCATE
INCATE - Supporting innovators to fight drug-resistant bacterial infections
About INCATE
INCATE - INCubator for Antimicrobial Therapies Europe – is a partnership which brings together translational and basic research, industry, experienced entrepreneurs and investors from across Europe and beyond. Our focus is on the development of new therapies, diagnostics and interventions that help reduce the prevalence and impact of Antimicrobial Resistance (AMR). INCATE helps early-stage innovators accelerate their AMR initiatives by providing funding, access to our community and advice on R&D and funding matters. When ready, innovators are encouraged to apply for Stage I for funding and detailed feedback from industry partners. Stage II projects receive greater funding and further support to build a company ready for the next stage of investment. Applications are accepted on a rolling basis. Get in touch with our scouting team or reach out to us via email at info@incate.net to find out how INCATE can help your AMR initiative.
Verified activity
Signals from INCATE
4 published signals
Presence & Recognition
INCATE is attending the 2026 Immunotherapies & Innovations for Infectious Diseases Congress in Lyon, France.
Reported by INCATE
Products & Services
INCATE announced that CARB-X's next Expression of Interest portal is open from November 10-23, 2026.
Reported by INCATE
Presence & Recognition
INCATE launched the newly-launched BEAM Alliance Fungi Task Force with an online home to learn about fungal diseases and expert teamwork.
Reported by INCATE
Presence & Recognition
INCATE hosted the Stage II Selection Committee Meeting on September 1, featuring five ventures pitching innovations for combating drug-resistant infections.
Reported by INCATE